Barely Significant

Excerpts

514,629 sentences

a significant trendp=0.020.4× alphagold
Using data on employment history, females showed a higher risk of moderate–severe asthma associated both with higher monthly number of night shifts (OR 1.39 (95% CI 1.04–1.88) for >10 night shifts per month; model 2, supplementary table 6 ) and with higher lifetime duration of night shifts (OR 1.28 (95% CI 1.03–1.59) for >10 years of night shifts; model 2, supplementary table 7 ), but a significant trend was found only among females for lifetime duration (p=0.02).
highly significantp = 0.020.4× alphaqualifiedgold
Both models show that the telehealth related factors are the most contributing features in predicting Effort Expectancy except for Self-Efficacy (SE) and Perceived Barriers (PB) where PB has a low contribution by lower IV, although it has a highly significant effect (a dashed border bar) on Effort Expectancy, inferred by p = 0.02 in Table 4 .
modestly significantP = 0.020.4× alphaqualifiedgold
In males too [ Table 8 ], the picture was more or less similar except that highest prevalence of hypercholesterolemia was seen in TH (12.5%) and not in the KO and the difference between the highest and the lowest levels (KA) was modestly significant statistically ( P = 0.02).
marginally significantp = 0.020.4× alphagold
Finally, 519 of these gene overlapped with the genes dysregulated in either autism, schizophrenia, bipolar disorder, depression or alcoholism [ 34 ], with a marginally significant overrepresentation for the schizophrenia group (Fisher’s exact test OR [95%CI] = 1.3 [1.04, Inf], p = 0.02, Supplementary Fig.
marginally significantp = 0.020.4× alphagold
Tissue biomarker changes Although the median decrease in Ki-67 change in non-obese participants was similar among the three dosing regimens, the median reduction of 4% in Ki67 in the TIW dose schedule in obese women was less than the 8% median reduction in the QD arm which was marginally significant ( p = 0.02).
borderline significantP = .020.4× alphagold
Univariate analysis of overall survival using the Cox model showed that stage ( P < .001), CA19-9 levels ( P = .004), and CRHR1 status ( P = .038) were significant factors, and the subsequent multivariate analysis revealed that of these, stage and postoperative CA19-9 levels were borderline significant factors ( P = .02 and .001, respectively) without multicollinearity ( Table 3 ).
marginally significantp = 0.020.4× alphagold
One-way ANOVA comparing scores between each odour group indicated no significant differences in LSAS on day 1 (pre-treatment) and SOS scores, whereas marginally significant differences in age were recorded, with Holm corrected post-hoc tests indicating a difference between the fear and clean air condition ( p = 0.02).
However, the associations for the vmPFC and left anterior insula did not reach statistical significance (pairwise correlations: left striatum, r = − 0.36, p = 0.02; right striatum, r = − 0.35, p = 0.03; left anterior insula, r = − 0.19, p = 0.23; right anterior insula, r = − 0.35, p = 0.02; vmPFC, r = − 0.22, p = 0.12).
nominally significantp = 0.020.4× alphagold
Given that there were strong positive correlations between the number of mutations of SBS1 and age at cancer diagnosis in breast cancer (Spearman’s ρ = 0.18, p = 2.50 × 10 −6 ), in colorectal cancer (Spearman’s ρ = 0.24, p = 2.85 × 10 −5 ), and in glioblastoma (Spearman’s ρ = 0.23, p = 1.11 × 10 −4 ); a nominally significant correlation between SBS1 and age in prostate cancer (Spearman’s ρ = 0.12, p = 0.02); and a significant correlation between SBS40 and age in endometrial cancer (Spearman’s ρ = 0.18, p = 9.67 × 10 −4 ), we further evaluated the associations of somatic mutations and PRS without adjusting for age at cancer diagnosis.
nominally significantP =0.020.4× alphagold
There was a nominally significant main effect for enhanced VASC in the higher-dose group ( t (36) =−2.48, P =0.02), HCQ ( t (36) =−2.75, P =0.009) and STAI ( t (36) =−2.48, P =0.01), indicating more craving and state anxiety due to cortisol administration for the higher-dose group.